Foghorn Therapeutics Inc. at Goldman Sachs Global Healthcare Conference Transcript
Maybe to start, Adrian, for those who are unfamiliar with Foghorn, can you maybe provide an overview of what is the gene traffic control platform and the various modalities and approaches that you employ to target the chromatin regulatory system?
Questions & Answers
Sure. Great. Thank you, Paul, and thanks to you and Goldman Sachs for having me here. My voice goes [about]; let me take a sip of water. The big idea behind Foghorn is one of altering and modulating gene expression through this chromatin regulatory system and to use maybe a simplifying analogy and the type of biology that we're working on and then I'll step through the modalities of how we think about the opportunity.
The analogy I often use is one of the architect and blueprint where if the genes are the blueprints, obviously, of the cell, then the chromatin regulatory system is the actual architect. And so, you can imagine if one hijacks the architect as what
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
